Intron Biotechnology, Inc.

Hyundai Motor Company

Kia Motors Corporation

Industry-university Cooperation Foundation Hanyang University

Hyun Jin Yu

SAng Hyeon Kang

Seong Jun Yoon

Soo Youn Jun

Jee Soo Son

Hyoung Rok Paik

In Hwang Kim

Hyun Joo Im

Dong Wook Kim

Beom Seok Kim

Jin Young Kim

Eun Jin Kim

Ji Young Park

Sang Suk Yang

Geun Woo Lee

Min Chan Jung

Ji Yeong Seo

Cheol Ahn

Tae Yeol Kim

A composition for preventing or treating an infection or disease caused by a pathogenicincludes a Podoviridae bacteriophage (Esc-COP-30) having an ability to lyse the pathogenicand a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenicincludes administering to a subject a Podoviridae bacteriophage and lysing the pathogenicby the Podoviridae bacteriophage.

Compositions and methods for inhibiting the proliferation of pathogenic

A composition for preventing or treating an infection or disease caused by a pathogenicincludes a Myoviridae bacteriophage Esc-COP-18 having an ability to lyse the pathogenicand a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenicincludes administering to a subject a Myoviridae bacteriophage and lysing the pathogenicby the Myoviridae bacteriophage.

A composition for preventing or treating an infection or disease caused by a pathogenicincludes a Myoviridae bacteriophage having an ability to lyse the pathogenicand a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenicincludes administering to a subject a Myoviridae bacteriophage and lysing the pathogenicby the Myoviridae bacteriophage.

The present invention relates to a plasmid-based CTX phage replication system andstrain that can be infected by CTX phage and can be used for cholera toxin production. More particularly, the present invention provides avariant strain, which expresses a toxT protein in which tyrosine at position 139 is substituted by phenylalanine through the point mutation of a toxT gene using a plasmid-based CTX phage replication system, and is used as a receptor strain which can improve CTX phage infection efficiency and allows a plurality of CTX prophages to simultaneously infect the strain and to be inserted into the chromosome thereof, which the consequent provision of the effect of increasing the production yield of a cholera toxin.

Plasmid-based CTX phage replication system and vibrio cholerae strain that can be infected by CTX phage and can be used for cholera toxin production

A method of controlling launch of a vehicle may include checking a start condition of the vehicle by a controller, determining whether only predetermined launch creep control torque is set as additional torque or whether the launch creep control torque and predetermined launch pre control torque are set together as the additional torque according to whether an accelerator pedal is manipulated when the start condition is satisfied, by the controller, setting the additional torque by adding launch slip control torque determined in consideration of a wheel speed difference between opposite driving wheels to the additional torque upon determining that the wheel speed difference is greater than a predetermined reference wheel speed, by the controller, and controlling an electric limited slip differential (eLSD) using the set additional torque, by the controller.

Method of controlling launch of vehicle

Growing community of inventors

Incheon, South Korea

Hyun Jin Yu